Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPF Induction vs PF Adjuvant Chemotherapy in High-Risk Nasopharyngeal Carcinoma
NCT03306121Phase 3Active, not recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Nov 2017
- Primary completion
- Dec 2023
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of liposomal paclitaxel in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Started Nov 2017; status: active, not recruiting.
02
Drugs
liposomal paclitaxel
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT03306121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03306121.